Alpenglow’s 3Deep Imager and AI tools featured as key driver of innovation in 3D Pathology

Written By Alex Springer

As 3D pathology continues to grow, understanding the benefits and drawbacks of the technology is increasingly important in deciding which diagnostic route to take. Lifesciences Intelligence took a deep dive with CEO Nick Reder to understand the implications, benefits, and challenges of 3D Pathology using Alpenglow’s innovative 3Deep technology platform.

Alex Springer
Previous

Alpenglow accelerates progress with key commercial hires including Spatial Biology industry veterans
Next

Alpenglow’s 3D Spatial Biology platform supports Cell Reports journal publication with 3D imaging of intact prostates